Gestoxen 300 SR Tablet contains 300 mg of natural micronized progesterone, a bioidentical hormone essential for maintaining various physiological functions related to the female reproductive system. This sustained-release formulation ensures a gradual and consistent release of progesterone, optimizing therapeutic efficacy and minimizing fluctuations in hormone levels. Progesterone plays a critical role in regulating the menstrual cycle, supporting early pregnancy, and preparing the endometrium for implantation. Gestoxen 300 SR is primarily indicated for the treatment of progesterone deficiency states, including luteal phase support in assisted reproductive technologies, management of menstrual irregularities, and prevention of threatened or recurrent miscarriage. Additionally, it may be used in hormone replacement therapy (HRT) to counteract estrogen-induced endometrial hyperplasia in postmenopausal women. The natural micronized form enhances bioavailability and tolerability compared to synthetic progestins. Administration should follow medical guidance, with dosage tailored to individual patient needs and clinical response. Common side effects may include mild dizziness, headache, breast tenderness, or gastrointestinal discomfort. Contraindications include known hypersensitivity to progesterone or any component of the formulation, active thromboembolic disorders, and hormone-dependent malignancies. Regular monitoring and follow-up are recommended to ensure safety and therapeutic effectiveness during treatment with Gestoxen 300 SR Tablet.